Clinical Trials Logo

Clinical Trial Summary

The current study would examine whether increases in endogenous dopaminergic activity via tyrosine and the (presumed) excitation of these by anodal tDCS of the dlPFC could causally be related to cognitive flexibility as measured by task switching and reversal learning.

Additionally, the study will test whether the Val158Met-polymorphism in the catechol- O-methyltransferase (COMT) gene could also predict the effect of TYR supplementation, as this gene is involved in DA degradation in the prefrontal cortex.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Modulation of Cognitive Flexibility by Transcranial Direct Current Stimulation, Tyrosine Administration and Polymorphisms in the COMT Gene

NCT number NCT03845920
Study type Interventional
Source Sheffield Hallam University
Contact Luca Aquili, Ph.D.
Phone + 44 (0) 114 225
Email luca.aquili@shu.ac.uk
Status Recruiting
Phase N/A
Start date February 18, 2019
Completion date September 30, 2019